Abstract:SOXC factors identified as transcriptional activators, act as transcriptional repressors, in glioblastoma. They achieve this by recruiting TRIM28 to suppress the expression of ECT2, a RhoGEF. This suppression results in the differential regulation of RhoA, RAC1, and CDC42 activities throughout the reprogramming process. Background Glioblastoma represents the most frequently diagnosed malignant neoplasm within the central nervous system. Human glioblastoma cells can be phenotypically reprogrammed into neuron‐like cells through the forced expression of NEUROG2 and SOXC factors. NEUROG2 serves as a pioneer factor, establishing an initial framework for this transformation. However, the specific role of SOXC factors has not been fully elucidated. Methods In this study, we used ChIP‐seq to determine the potential target gene of NGN2. RNA‐seq has been used to evaluate the transcriptional change during NGN2‐SOX11‐mediated neuron reprogramming. Immunofluorescence was used to determine the neuron reprogramming efficacy and cell proliferation ability. ChIP‐qPCR, Co‐IP, and Western Blot were performed to investigate the mechanism. Results Our findings reveal that SOXC factors, in contrast to their previously identified function as transcriptional activators, act as transcriptional repressors. They achieve this by recruiting TRIM28 to suppress the expression of ECT2, a RhoGEF. This suppression results in the differential regulation of RhoA, RAC1, and CDC42 activities throughout the reprogramming process. We further establish that small molecules targeting RhoA and its effectors can substitute for SOXC factors in facilitating the neuronal reprogramming of glioblastoma cells. Conclusion These results underscore the pivotal role of SOXC factors' transcriptional repression and illuminate one of their specific downstream targets.

Sox2 acts as a transcriptional repressor in neural stem cells

Sox2, a Key Factor in the Regulation of Pluripotency and Neural Differentiation

SUMO-dependent transcriptional repression by Sox2 inhibits the proliferation of neural stem cells

A Sox2 Enhancer Cluster Regulates Region-Specific Neural Fates from Mouse Embryonic Stem Cells

Sox2 Protects Neural Stem Cells from Apoptosis Via Up-Regulating Survivin Expression.

SOX2 Modulates Reprogramming of Gene Expression in Two-Cell Mouse Embryos1

Overview of the Roles of Sox2 in Stem Cell and Development

Comprehensive Profiling Reveals Mechanisms of SOX2-mediated Cell Fate Specification in Human ESCs and NPCs

Sox2 directly activate Olig2 transcription in neural stem cells

Sox14 is essential for initiation of neuronal differentiation in the chick spinal cord

Bioinformatics Analysis Makes Revelation to Potential Properties on Regulation and Functions of Human Sox2

SOX1 Is Required for the Specification of Rostral Hindbrain Neural Progenitor Cells from Human Embryonic Stem Cells

SOXC Enhances NGN2‐Mediated Reprogramming of Glioblastoma Cells Into Neuron‐Like Cells by Modulating RhoA and RAC1/CDC42 Pathway Activity

OCT4 and PAX6 Determine the Dual Function of SOX2 in Human ESCs As a Key Pluripotent or Neural Factor.

Site-Specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition

An Acetylation-Enhanced Interaction Between Transcription Factor Sox2 and the Steroid Receptor Coactivators Facilitates Sox2 Transcriptional Activity and Function.

Sox21 homeologs autoregulate expression levels to control progression through neurogenesis

Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate

Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells

The multiple roles for Sox2 in stem cell maintenance and tumorigenesis

Sox2 levels regulate the chromatin occupancy of WNT mediators in epiblast progenitors responsible for vertebrate body formation